- Home
- LEXX vs ICMB Comparison
LEXX vs ICMB Comparison
Compare LEXX & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- ICMB
- Stock Information
- Founded
- LEXX 2004
- ICMB 2012
- Country
- LEXX Canada
- ICMB United States
- Employees
- LEXX N/A
- ICMB N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- LEXX Health Care
- ICMB Finance
- Exchange
- LEXX Nasdaq
- ICMB Nasdaq
- Market Cap
- LEXX 43.5M
- ICMB 48.0M
- IPO Year
- LEXX N/A
- ICMB N/A
- Fundamental
- Price
- LEXX $2.01
- ICMB $3.06
- Analyst Decision
- LEXX Strong Buy
- ICMB
- Analyst Count
- LEXX 2
- ICMB 0
- Target Price
- LEXX $11.00
- ICMB N/A
- AVG Volume (30 Days)
- LEXX 148.5K
- ICMB 42.9K
- Earning Date
- LEXX 01-10-2025
- ICMB 11-12-2024
- Dividend Yield
- LEXX N/A
- ICMB 15.69%
- EPS Growth
- LEXX N/A
- ICMB N/A
- EPS
- LEXX N/A
- ICMB 0.29
- Revenue
- LEXX $411,019.00
- ICMB $24,827,371.00
- Revenue This Year
- LEXX $82.02
- ICMB N/A
- Revenue Next Year
- LEXX $95.09
- ICMB N/A
- P/E Ratio
- LEXX N/A
- ICMB $10.49
- Revenue Growth
- LEXX 34.05
- ICMB N/A
- 52 Week Low
- LEXX $1.20
- ICMB $2.91
- 52 Week High
- LEXX $6.85
- ICMB $3.96
- Technical
- Relative Strength Index (RSI)
- LEXX 26.93
- ICMB 49.55
- Support Level
- LEXX $2.20
- ICMB $2.91
- Resistance Level
- LEXX $2.42
- ICMB $3.00
- Average True Range (ATR)
- LEXX 0.19
- ICMB 0.08
- MACD
- LEXX -0.00
- ICMB 0.02
- Stochastic Oscillator
- LEXX 7.27
- ICMB 55.56
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.